Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0I9UP
|
|||
| Former ID |
DIB013289
|
|||
| Drug Name |
HBX-41108
|
|||
| Synonyms |
USP inhibitors (cancer), Hybrigenics; USP-7 inhibitors, Hybrigenics; USP-7 inhibitors (cancer), Hybrigenics; USP-9 inhibitors (cancer), Hybrigenics; Ubiquitin-specific protease inhibitors (cancer), Hybrigenics; Ubiquitin-specific protease-7 inhibitors (cancer), Hybrigenics
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Preclinical | [1] | |
| Company |
Hybrigenics SA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H3ClN4O
|
|||
| Canonical SMILES |
C1=CC2=C(C=C1Cl)C(=O)C3=NC(=C(N=C23)C#N)C#N
|
|||
| InChI |
1S/C13H3ClN4O/c14-6-1-2-7-8(3-6)13(19)12-11(7)17-9(4-15)10(5-16)18-12/h1-3H
|
|||
| InChIKey |
BIGPXXAUSQLTQR-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 924296-39-9
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018 Jan;17(1):57-78. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.